|
gptkbp:instanceOf
|
gptkb:naphthoylindole
gptkb:synthetic_cannabinoid
|
|
gptkbp:actsOn
|
gptkb:cannabinoid_receptor_agonist
|
|
gptkbp:binds
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
|
gptkbp:CASNumber
|
864445-01-4
|
|
gptkbp:category
|
gptkb:recreational_drug
gptkb:indole
gptkb:naphthoylindole
phenylacetylindole
|
|
gptkbp:chemicalFormula
|
C22H25NO2
|
|
gptkbp:discoveredBy
|
gptkb:John_W._Huffman
|
|
gptkbp:firstSynthesized
|
mid-2000s
|
|
gptkbp:IUPACName
|
1-pentyl-3-(2-methoxyphenylacetyl)indole
|
|
gptkbp:legal_status_in_Germany
|
Anlage II controlled substance
|
|
gptkbp:legal_status_in_United_Kingdom
|
Class B drug
|
|
gptkbp:legal_status_in_United_States
|
Schedule I controlled substance
|
|
gptkbp:molecularWeight
|
335.44 g/mol
|
|
gptkbp:namedAfter
|
gptkb:John_W._Huffman
|
|
gptkbp:PubChem_CID
|
44418399
|
|
gptkbp:relatedTo
|
gptkb:JWH-018
gptkb:JWH-073
gptkb:JWH-081
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
|
|
gptkbp:UNII
|
2Q8T3466QK
|
|
gptkbp:used_in
|
synthetic cannabis products
|
|
gptkbp:bfsParent
|
gptkb:JWH_cannabinoids
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
JWH-250
|